Objective.-Banking umbilical cord blood (UCB) to be used as a source o
f stem cells for transplantation is associated with a set of ethical i
ssues. An examination of these issues is needed to inform public polic
y and to raise the awareness of prospective parents, clinicians, and i
nvestigators. Participants.-Individuals with expertise in anthropology
, blood banking, bone marrow transplantation, ethics, law, obstetrics,
pediatrics, and the social sciences were invited to join the Working
Group on Ethical Issues in Umbilical Cord Blood Banking. Evidence.-Mem
bers were assigned topics to present to the Working Group. Following i
ndependent reviews, background materials were sent to the Working Grou
p. Consensus Process.-Individual presentations of topics at a 2-day me
eting were followed by extensive group discussions in which consensus
emerged. A writing committee then drafted a document that was circulat
ed to the entire Working Group. After 3 rounds of comments over severa
l months, all but 1 member of the Working Group agreed with the presen
tation of our conclusions. Conclusions.-(1) Umbilical cord blood techn
ology is promising although it has several investigational aspects; (2
) during this investigational phase, secure linkage should be maintain
ed of stored UCB to the identity of the donor; (3) UCB banking for aut
ologous use is associated with even greater uncertainty than banking f
or allogeneic use; (4) marketing practices for UCB banking in the priv
ate sector need close attention; (5) more data are needed to ensure th
at recruitment for banking and use of UCB are equitable; and (6) the p
rocess of obtaining informed consent for collection of UCB should begi
n before labor and delivery.